Sort
50,496 grants matching “lung cancer”
Epidemiology of Venous Thrombosis and Pulmonary Embolism
$865,654Weihong Tang · University Of Minnesota · R01 · FY2022 · HL
NRG Oncology Biospecimen Bank
$865,475Richard C Jordan · Nrg Oncology Foundation, Inc. · U24 · FY2020 · CA
Mouse Models for Human Cancer
$865,467Brigham And Women'S Hospital · U01 · FY2005 · CA
Development of Drugs Acting at Adenosine Receptors
$865,266Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Modeling Airway Lung Cancer and the Role of Inflammation
$865,166Francesco John Demayo · Baylor College Of Medicine · U01 · FY2006 · CA
Tethosomes: a non-viral DNA platform for durable expression of therapeutic transgenes in specific target cells
$865,162Benjamin Richard Hawley · Engage Biologics Inc. · R44 · FY2025 · TR
CLUE STUDIES--EVALUATING BIOMARKERS OF CARCINOGENESIS
$865,161Johns Hopkins University · U01 · FY2001 · CA
Sealing Air Leaks by Inductive Coagulation Following Lung Surgery
$865,071Kevin Marchitto · Rocky Mountain Biosystems, Inc. · R44 · FY2009 · HL
Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform
$865,070Ian Paul Winters · D2g Oncology, Inc. · R44 · FY2021 · CA
HFH-MSU CSRN ACCrual Enrollment and Screening Site
$864,728Christine Marie Neslund-Dudas · Henry Ford Health + Michigan State University Health Sciences · UG1 · FY2024 · CA
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
$864,597Tracy T Batchelor · Brigham And Women'S Hospital · U19 · FY2023 · CA
Preclinical Development of a Novel and Powerful Immunotherapeutic
$864,478Susan Dana Jones · Immurx Llc · R44 · FY2013 · AI
Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors
$864,461R.t Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Investigation of lung tumor development and treatment u*
$864,356Tyler E Jacks · Massachusetts Institute Of Technology · U01 · FY2006 · CA
Dayton Clinical Oncology Program
$864,347Howard M Gross · Dayton Clinical Oncology Program · U10 · FY2007 · CA
Modeling Airway Lung Cancer and the Role of Inflammation
$863,870Francesco John Demayo · Baylor College Of Medicine · U01 · FY2007 · CA
Base Excision DNA Repair in Disease Susceptibility and Treatment
$863,862David Wilson · National Institute On Aging · ZIA · FY2018 · AG
Genes contributing for nicotine dependence in humans
$863,787Kari Stefansson · Decode Genetics, Ehf · R01 · FY2011 · DA
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$863,755Jyothi Rengarajan · Emory University · R01 · FY2024 · AI
Tissue factor-dependent coagulation in thrombosis and immune responses
$863,736Nigel Mackman · Univ Of North Carolina Chapel Hill · R35 · FY2021 · HL
Clinical trials employing cancer vaccine combination therapies
$863,733James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$863,733James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
$863,700Debra L Friedman · Vanderbilt University Medical Center · R01 · FY2020 · CA
NIH Chronic GVHD Study Group
$863,692Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$863,617Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA